Top section
Top section
I thought the grass would be greener in fintech land, but it’s patchy and dreary
Hybrid capital is open to the big US tech companies. But who needs an umbrella when the sun is shining?
Years of underperformance are behind it and the bank has launched a new growth plan
More articles
More articles
More articles
-
Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has filed preliminary IPO documents with India’s securities regulator for a listing. -
Electric vehicle maker Li Auto is planning to float American Depository Shares (ADS) on the Nasdaq. It is eyeing $100m in proceeds.
-
Brockhaus Capital Management (BCM), an investment firm focused on acquiring high growth tech companies, has priced an IPO in Frankfurt raising funds for further acquisitions.
-
China Bohai Bank has priced its Hong Kong listing just off the floor of the marketed range to raise HK$13.8bn ($1.78bn).
-
Chinese private equity firm Yunfeng Capital trimmed its position in Alibaba Health Information Technology with an upsized block trade on Thursday, its second sale of the stock this year.
-
JP Morgan has extended its lead in European investment banking, scotching accusations of a retreat and dashing hopes of a change in the status quo, writes David Rothnie.
Sub-sections
shared comment list
